Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Update

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 75,000 shares, an increase of 74,900.0% from the September 15th total of 100 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 750.0 days. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 750.0 days.

Santhera Pharmaceuticals Stock Performance

Shares of OTCMKTS SPHDF opened at $12.28 on Friday. The stock’s 50-day simple moving average is $16.81 and its two-hundred day simple moving average is $16.42. Santhera Pharmaceuticals has a twelve month low of $12.28 and a twelve month high of $19.00.

About Santhera Pharmaceuticals

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).